M
Microba Life Sciences Ltd
ASX:MAP
Microba Life Sciences Ltd
ASX:MAP
Price:
0.078
AUD
-2.5%
Market Closed
Market Cap:
AU$47.5m
Balance Sheet
Balance Sheet Decomposition
Microba Life Sciences Ltd
Microba Life Sciences Ltd
Balance Sheet Decomposition is not available for
Microba Life Sciences Ltd
Microba Life Sciences Ltd
Balance Sheet
Microba Life Sciences Ltd
Microba Life Sciences Ltd
Currency: AUD
| Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
11
|
7
|
13
|
26
|
31
|
21
|
11
|
|
| Cash |
11
|
7
|
13
|
26
|
19
|
17
|
8
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
12
|
4
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
2
|
3
|
7
|
8
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
1
|
|
| Other Receivables |
0
|
0
|
1
|
3
|
7
|
6
|
3
|
|
| Inventory |
0
|
0
|
1
|
0
|
1
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
1
|
6
|
3
|
1
|
2
|
|
| Total Current Assets |
12
|
8
|
16
|
36
|
42
|
32
|
19
|
|
| PP&E Net |
2
|
2
|
1
|
3
|
3
|
4
|
4
|
|
| PP&E Gross |
2
|
2
|
1
|
3
|
3
|
4
|
4
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
4
|
6
|
8
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
3
|
13
|
15
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
9
|
10
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
9
|
10
|
|
| Total Assets |
14
N/A
|
11
-23%
|
18
+71%
|
39
+114%
|
47
+19%
|
59
+25%
|
47
-19%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
4
|
5
|
4
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
2
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Other Current Liabilities |
0
|
1
|
1
|
1
|
1
|
5
|
2
|
|
| Total Current Liabilities |
1
|
3
|
3
|
5
|
8
|
12
|
10
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
1
|
|
| Total Liabilities |
1
N/A
|
3
+116%
|
4
+14%
|
6
+67%
|
8
+41%
|
17
+108%
|
15
-14%
|
|
| Equity | ||||||||
| Common Stock |
18
|
19
|
33
|
63
|
80
|
103
|
109
|
|
| Retained Earnings |
5
|
12
|
19
|
29
|
42
|
62
|
76
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
13
N/A
|
8
-39%
|
15
+94%
|
34
+125%
|
39
+15%
|
41
+7%
|
32
-21%
|
|
| Total Liabilities & Equity |
14
N/A
|
11
-23%
|
18
+71%
|
39
+114%
|
47
+19%
|
59
+25%
|
47
-19%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
274
|
274
|
291
|
291
|
365
|
448
|
515
|
|
Switch to:
Switch to:
See Also
Discover More
